Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 EUR | 0.00% | -3.93% | -7.07% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2023 * | 10.8M 11.57M 924M | Sales 2024 * | 16.2M 17.36M 1.39B | Capitalization | 50.35M 53.95M 4.31B |
---|---|---|---|---|---|
Net income 2023 * | - 0 0 | Net income 2024 * | - | EV / Sales 2023 * | 4.78 x |
Net Debt 2023 * | 1.3M 1.39M 111M | Net Debt 2024 * | 1.9M 2.04M 163M | EV / Sales 2024 * | 3.23 x |
P/E ratio 2023 * |
-85.5
x | P/E ratio 2024 * |
-
| Employees | 58 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 21.08% |
1 week | -3.93% | ||
Current month | -8.06% | ||
1 month | -8.06% | ||
3 months | -2.84% | ||
6 months | -16.99% | ||
Current year | -7.07% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.71 | 0.00% | 0 |
25/04/24 | 1.71 | 0.00% | 2,800 |
24/04/24 | 1.71 | -3.93% | 3,911 |
23/04/24 | 1.78 | +2.89% | 1,384 |
22/04/24 | 1.73 | -2.81% | 1,488 |
Delayed Quote BME, April 26, 2024 at 03:00 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.07% | 53.75M | |
+1.51% | 42.75B | |
+47.87% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PANG Stock